Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Catalent Total Long Term Liabilities 2012-2024 | CTLT

Catalent total long term liabilities from 2012 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
  • Catalent total long term liabilities for the quarter ending September 30, 2024 were $5.168B, a 11.19% increase year-over-year.
  • Catalent total long term liabilities for 2024 were $5.118B, a 10.4% increase from 2023.
  • Catalent total long term liabilities for 2023 were $4.636B, a 0.02% increase from 2022.
  • Catalent total long term liabilities for 2022 were $4.635B, a 27.27% increase from 2021.
  
Catalent Annual Total Long Term Liabilities
(Millions of US $)
2024 $5,118
2023 $4,636
2022 $4,635
2021 $3,642
2020 $3,378
2019 $3,225
2018 $2,868
2017 $2,262
2016 $2,064
2015 $2,105
2014 $3,009
2013 $2,950
2012 $3,050
2011 $
Catalent Quarterly Total Long Term Liabilities
(Millions of US $)
2024-09-30 $5,168
2024-06-30 $5,118
2024-03-31 $5,261
2023-12-31 $5,265
2023-09-30 $4,648
2023-06-30 $4,636
2023-03-31 $4,640
2022-12-31 $4,709
2022-09-30 $4,562
2022-06-30 $4,635
2022-03-31 $4,644
2021-12-31 $4,677
2021-09-30 $4,707
2021-06-30 $3,642
2021-03-31 $3,558
2020-12-31 $3,360
2020-09-30 $3,386
2020-06-30 $3,378
2020-03-31 $3,368
2019-12-31 $3,215
2019-09-30 $3,248
2019-06-30 $3,225
2019-03-31 $2,347
2018-12-31 $2,364
2018-09-30 $2,443
2018-06-30 $2,868
2018-03-31 $2,928
2017-12-31 $2,898
2017-09-30 $2,289
2017-06-30 $2,262
2017-03-31 $2,252
2016-12-31 $2,232
2016-09-30 $2,065
2016-06-30 $2,064
2016-03-31 $2,083
2015-12-31 $2,088
2015-09-30 $2,106
2015-06-30 $2,105
2015-03-31 $2,141
2014-12-31 $2,199
2014-09-30 $2,071
2014-06-30 $3,009
2014-03-31 $3,078
2013-12-31 $3,057
2013-09-30
2013-06-30 $3,057
2013-03-31
2012-06-30 $3,050
2011-06-30
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $10.784B $4.381B
Catalent, Inc. is a renowned global provider of advanced delivery technologies as well as development and manufacturing solutions for drugs (protein, cell, and gene therapy biologics) and consumer health products.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.775B 30.70
Takeda Pharmaceutical (TAK) Japan $43.846B 9.13
Merck (MKKGY) Germany $21.021B 22.94
Astellas Pharma (ALPMY) Japan $20.214B 18.62
Sandoz Group AG (SDZNY) Switzerland $19.826B 0.00
United Therapeutics (UTHR) United States $18.304B 18.01
Summit Therapeutics (SMMT) United States $15.789B 0.00
Neurocrine Biosciences (NBIX) United States $12.731B 33.71
Shionogi (SGIOY) Japan $12.473B 11.95
Madrigal Pharmaceuticals (MDGL) United States $7.649B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.633B 7.31
Orion OYJ (ORINY) Finland $6.848B 19.25
Corcept Therapeutics (CORT) United States $6.245B 47.30
Ionis Pharmaceuticals (IONS) United States $6.188B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.857B 0.00
PTC Therapeutics (PTCT) United States $3.406B 0.00
Dyne Therapeutics (DYN) United States $2.859B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.854B 12.94
Arrowhead Pharmaceuticals (ARWR) United States $2.721B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.702B 16.17
Soleno Therapeutics (SLNO) United States $2.460B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.171B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.996B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.870B 0.00
Harrow (HROW) United States $1.863B 0.00
Ocular Therapeutix (OCUL) United States $1.731B 0.00
Xencor (XNCR) United States $1.653B 0.00
ARS Pharmaceuticals (SPRY) United States $1.652B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.611B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.535B 0.00
Evotec AG (EVO) Germany $1.464B 0.00
Indivior (INDV) United States $1.413B 5.76
Enliven Therapeutics (ELVN) United States $1.368B 0.00
Guardian Pharmacy Services (GRDN) United States $1.329B 0.00
Cassava Sciences (SAVA) United States $1.293B 0.00
Ardelyx (ARDX) United States $1.201B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.190B 0.00
Collegium Pharmaceutical (COLL) United States $1.036B 5.66
Bioventus (BVS) United States $0.957B 30.31
Relay Therapeutics (RLAY) United States $0.830B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.792B 0.00
USANA Health Sciences (USNA) United States $0.767B 14.22
Cronos Group (CRON) Canada $0.765B 0.00
Tourmaline Bio (TRML) United States $0.737B 0.00
Exscientia (EXAI) United Kingdom $0.658B 0.00
Korro Bio (KRRO) United States $0.655B 0.00
Savara (SVRA) United States $0.653B 0.00
ProKidney (PROK) United States $0.579B 0.00
Larimar Therapeutics (LRMR) United States $0.569B 0.00
Altimmune (ALT) United States $0.546B 0.00
Elite Pharmaceuticals (ELTP) United States $0.545B 50.98
Siga Technologies (SIGA) United States $0.540B 6.31
Verve Therapeutics (VERV) United States $0.534B 0.00
OmniAb (OABI) United States $0.534B 0.00
Silence Therapeutics (SLN) United Kingdom $0.524B 0.00
Xeris Biopharma Holdings (XERS) United States $0.517B 0.00
Aquestive Therapeutics (AQST) United States $0.498B 0.00
KalVista Pharmaceuticals (KALV) United States $0.493B 0.00
Zevra Therapeutics (ZVRA) United States $0.474B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.456B 0.00
Esperion Therapeutics (ESPR) United States $0.447B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.437B 0.00
Organogenesis (ORGO) United States $0.435B 0.00
4D Molecular Therapeutics (FDMT) United States $0.422B 0.00
Akebia Therapeutics (AKBA) United States $0.408B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.388B 157.64
Sage Therapeutics (SAGE) United States $0.386B 0.00
Aldeyra Therapeutics (ALDX) United States $0.328B 0.00
Lyell Immunopharma (LYEL) United States $0.312B 0.00
Avita Medical (RCEL) United States $0.311B 0.00
Nature's Sunshine Products (NATR) United States $0.276B 16.37
Acrivon Therapeutics (ACRV) United States $0.265B 0.00
Heron Therapeutics (HRTX) United States $0.265B 0.00
Lexeo Therapeutics (LXEO) United States $0.264B 0.00
Pyxis Oncology (PYXS) United States $0.263B 0.00
Nektar Therapeutics (NKTR) United States $0.258B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.235B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.226B 0.00
Profound Medical (PROF) Canada $0.216B 0.00
Nanobiotix S.A (NBTX) France $0.198B 0.00
Aclaris Therapeutics (ACRS) United States $0.189B 0.00
Galectin Therapeutics (GALT) United States $0.187B 0.00
MediWound (MDWD) Israel $0.186B 0.00
Innate Pharma SA (IPHYF) France $0.180B 0.00
Incannex Healthcare (IXHL) Australia $0.176B 0.00
Achieve Life Sciences (ACHV) Canada $0.159B 0.00
Cardiol Therapeutics (CRDL) Canada $0.159B 0.00
CytoDyn (CYDY) United States $0.150B 0.00
Context Therapeutics (CNTX) United States $0.146B 0.00
Telomir Pharmaceuticals (TELO) United States $0.125B 0.00
Century Therapeutics (IPSC) United States $0.122B 0.00
VAXART, INC (VXRT) United States $0.122B 0.00
Fractyl Health (GUTS) United States $0.118B 0.00
OptiNose (OPTN) United States $0.118B 0.00
Journey Medical (DERM) United States $0.117B 0.00
Karyopharm Therapeutics (KPTI) United States $0.110B 0.00
Relmada Therapeutics (RLMD) United States $0.099B 0.00
Regulus Therapeutics (RGLS) United States $0.096B 0.00
Arch Biopartners (ACHFF) Canada $0.094B 0.00
PMV Pharmaceuticals (PMVP) United States $0.090B 0.00
ElectroCore (ECOR) United States $0.087B 0.00
CASI Pharmaceuticals (CASI) China $0.085B 0.00
Assertio Holdings (ASRT) United States $0.081B 14.17
ESSA Pharma (EPIX) Canada $0.080B 0.00
Inotiv (NOTV) United States $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.67
Metagenomi (MGX) United States $0.076B 0.00
Citius Pharmaceuticals (CTXR) United States $0.074B 0.00
AlloVir (ALVR) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Prelude Therapeutics (PRLD) United States $0.065B 0.00
Champions Oncology (CSBR) United States $0.061B 0.00
Mural Oncology (MURA) Ireland $0.060B 0.00
Nutriband (NTRB) United States $0.059B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Unicycive Therapeutics (UNCY) United States $0.056B 0.00
BGM Group (BGM) China $0.053B 0.00
Protara Therapeutics (TARA) United States $0.052B 0.00
SCYNEXIS (SCYX) United States $0.050B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
VYNE Therapeutics (VYNE) United States $0.047B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
DURECT (DRRX) United States $0.041B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
BioLineRx (BLRX) Israel $0.036B 0.00
Surrozen (SRZN) United States $0.033B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Oruka Therapeutics (ORKA) United States $0.032B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.031B 0.00
Natural Alternatives (NAII) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
GlycoMimetics (GLYC) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
BioVie (BIVI) United States $0.026B 0.00
Lipocine (LPCN) United States $0.025B 0.00
Inhibikase Therapeutics (IKT) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.020B 0.71
Tonix Pharmaceuticals Holding (TNXP) United States $0.019B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.019B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
Talphera (TLPH) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
NRx Pharmaceuticals (NRXP) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
Indaptus Therapeutics (INDP) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.011B 0.00
CERo Therapeutics Holdings (CERO) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Conduit Pharmaceuticals (CDT) United States $0.010B 0.00
Redhill Biopharma (RDHL) Israel $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
Ainos (AIMD) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.09
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Molecular Templates (MTEM) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 2.98
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 42.71